Top Markets
#1 Black Phoenix Black Phoenix +167.32%
#2 Islamic Coin Islamic Coin +158.13%
#3 Glidr Glidr +84.34%
#4 Acurast Acurast +40.13%
#5 Cryptopia Cryptopia +22.29%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.49%
#7 Quantum Resistant Ledger Quantum Resistant Ledger +17.26%
#8 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +14.50%
#9 Playnance Playnance +13.58%
#10 OVERTAKE OVERTAKE +13.24%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Oxford Cannabinoid Technologies Holdings Plc Oxford Cannabinoid Technologies Holdings Plc

Oxford Cannabinoid Technologies Holdings Plc

OCTP
Classifica tra le azioni #41532
Oxford Cannabinoid Technologies Holdings Plc operates as a pharmaceutical... Oxford Cannabinoid Technologies Holdings Plc operates as a pharmaceutical company, focused on the research, development, and commercialization of cannabinoid-derived prescription medications. Their principal drug candidate, OCT461201, is a selective CB2 receptor agonist in an oral solid dosage format, currently undergoing pre-clinical assessment. It is being developed to target visceral pain associated with Irritable Bowel Syndrome (IBS), as well as a range of neuropathic pain conditions, notably post-herpetic neuralgia. The company is also progressing with OCT130401, another compound in pre-clinical development, intended for the treatment of trigeminal neuralgia. Incorporated in 2017, Oxford Cannabinoid Technologies Holdings Plc is based in London, United Kingdom.
Prezzo delle azioni
$0.00156481
Ultima sincronizzazione: 2024-06-05
Capitalizzazione di mercato
$17.03K
Variazione (1 giorno)
2.11%
Variazione (1 anno)
0.00%
Paese
GB
Scambia Oxford Cannabinoid Technologies Holdings Plc (OCTP)

Categoria

Healthcare
Ricavi di Oxford Cannabinoid Technologies Holdings Plc (OCTP)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Oxford Cannabinoid Technologies Holdings Plc, i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Oxford Cannabinoid Technologies Holdings Plc da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE